|
Volumn 13, Issue 1, 2006, Pages 1-2
|
New AAV serotypes may broaden the therapeutic pipeline to human gene therapy
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA 1 ANTITRYPSIN;
DNA;
EPITOPE;
PARVOVIRUS VECTOR;
ALPHA 1 ANTITRYPSIN DEFICIENCY;
CYTOTOXIC T LYMPHOCYTE;
EDITORIAL;
GENE EXPRESSION;
GENE THERAPY;
GENE TRANSFER;
GENETIC DISORDER;
HUMAN;
IMMUNE RESPONSE;
IMMUNITY;
MEDICAL LITERATURE;
NONHUMAN;
SEROTYPE;
TRANSGENE;
VIRAL GENE DELIVERY SYSTEM;
VIRUS RECOMBINANT;
ALPHA 1-ANTITRYPSIN;
ANIMALS;
DEPENDOVIRUS;
GENE THERAPY;
GENE TRANSFER TECHNIQUES;
GENETIC VECTORS;
HUMANS;
IMMUNITY, NATURAL;
MICE;
PRIMATES;
SEROTYPING;
PARVOVIRUS;
|
EID: 28844480173
PISSN: 15250016
EISSN: None
Source Type: Journal
DOI: 10.1016/j.ymthe.2005.11.004 Document Type: Editorial |
Times cited : (2)
|
References (8)
|